Developer docs
API playgroundTry for free, no card

Search company profiles

PsyTech

Full company profile

uuid000qwi1

Namestring
PsyTech
Legal namestring
Psytech Global
Company typeenum
Private
Founded yearint
2019
Descriptiontext

PsyTech, operating legally as Psytech Global, is a privately held online media and information platform focused on psychedelic science, therapy, and industry. The company publishes articles covering psychedelic news, clinical research summaries, educational content, people profiles, and business developments across eight substance verticals (Ayahuasca, DMT, Ketamine, Kratom, MDMA, Mescaline, Peyote, and Psilocybin), and maintains a free daily email newsletter for subscriber engagement. Content is produced by a small team described as journalists, business education professionals, and medical doctors, with articles referencing peer-reviewed research from institutions including Harvard, Johns Hopkins, NYU, and UCLA.

The underlying product is a WordPress-based content website (psytechglobal.com) with no mobile app, no API, no proprietary software, and no documented AI or ML components; the technology stack is standard web publishing rather than a custom platform. Beyond editorial, PsyTech operates a narrow consumer-services arm providing sitter services and guided ceremony/retreat facilitation for psilocybin truffle experiences in the Netherlands, where such services are legal, and references the ICEERS facilitator-selection framework as a credibility reference.

Commercially, the business appears to rely on advertising and informal affiliate or referral relationships with smartshops and retreat providers; no pricing is disclosed and no enterprise or subscription products are offered. Customer segments are horizontal — the general public interested in psychedelics, mental health patients and advocates, and researchers/healthcare professionals — with no anchor accounts. Headcount is 1–10 employees, no funding rounds are disclosed, and the company is independently owned with no parent or known investor.

Short descriptiontext

PsyTech (Psytech Global) is a small online media platform that publishes news, research, education, and business coverage of psychedelics for the general public, mental health patients, and researchers, and offers guided psilocybin truffle experiences in the Netherlands.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersToronto, Canada
HQ citystring
Toronto
HQ countrystring
Canada
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
psychedelic news media, psychedelic education content, psychedelic research coverage, harm reduction information, clinical psychedelic reporting
NAICS code1 code
  • Advertising, Public Relations, and Related Services5418
SIC code1 code
  • Services-Advertising7310
Product category
Online Psychedelic News and Education Media
Social media profiles2 records
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1Content Publishing & Advertising
TypeAdvertising
Description

The company operates as an online media publication generating content about psychedelics including news, research summaries, educational articles, and people profiles. Revenue appears to be generated through advertising, sponsored content, and affiliate relationships with related services such as smartshops and retreat providers mentioned in their guided psychedelic experience article.

psytechglobal.com
Marketing channels3 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels2 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components4 values
Personnel, Operations, Marketing or Sales, Technology or R&D
GTM typeB2C
B2C
Offering typeDigital Commerce or Conte…
Digital Commerce or Content
Core offering1 text field

PsyTech (Psytech Global) operates a digital media publication at psytechglobal.com that publishes news, research summaries, educational articles, people profiles, and business coverage focused on psychedelics including psilocybin, LSD, MDMA, ketamine, ayahuasca, DMT, mescaline, peyote, and kratom. Content is produced by journalists, business education professionals, and medical doctors and distributed free of charge through the website and a daily email newsletter. In addition, PsyTech offers sitter and guided ceremony integration services in the Netherlands where psilocybin truffles are legally available through smartshops.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 value
  • Articles regularly cited and linked to peer-reviewed research from institutions including Harvard, Johns Hopkins, NYU, UCLA, and major pharmaceutical organizations
Product overview1 text field

PsyTech Global is a content and education platform that publishes psychedelic-related news, research articles, and informational content. The platform covers various psychedelic substances including psilocybin, LSD, MDMA, ketamine, ayahuasca, DMT, mescaline, and peyote through educational articles, research summaries, and people profiles. It does not appear to offer a software product or application with technical integrations.

Product and service3 records
1PsyTech Global Content Platform
CategoryDigital Media / Online Publication
Description

A free online publication providing news, research summaries, educational articles, people profiles, and business coverage focused on psychedelics. It is targeted at general consumers, mental health patients and advocates, researchers, and healthcare professionals, and covers substance-specific categories (Ayahuasca, DMT, Ketamine, Kratom, MDMA, Mescaline, Peyote, Psilocybin).

2PsyTech Daily Email Newsletter
CategoryNewsletter / Email Subscription
Description

A free daily email newsletter subscription delivering brief updates on psychedelic industry news, research, and developments to subscribed readers, supporting recurring audience engagement.

3PsyTech Integration and Guided Ceremony Services (Netherlands)
CategoryIntegration / Sitter Services
Description

In-person sitter and guided ceremony services for individuals seeking supported psilocybin truffle experiences in the Netherlands. Offered to consumers in jurisdictions where such services are legal and uses ICEERS-aligned criteria for selecting safe facilitators.

Scale indicator1 record

Each record includes

Type, Value, Description, Source

Partnership1 partner
Strategic tierMinorTypeOthers
Description

PsyTech references ICEERS guidelines for criteria for selecting psychedelic ceremony facilitators. ICEERS provides education and research services for ethnobotanical substances. PsyTech uses their framework as a basis for their own guidance on selecting safe psychedelic experiences.

Recent move5 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight4 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Psychedelic journalism outlet covering policy, research, and business. Direct peer in the psychedelic-media category with similar news/research/business verticals to PsyTech.

TypeDirect peer
Description

Editorial-led psychedelic media outlet covering news, culture, and policy. Closest direct competitor to PsyTech's content-publishing model and target audience of curious consumers, patients, and professionals.

3Third Wave
TypeDirect peer
Description

Psychedelic education and media platform offering articles, courses, and a coaching directory. Comparable to PsyTech in vertical specialization and content-led GTM, with an additional layer of paid training services.

TypeDirect peer
Description

Research-focused publication summarizing peer-reviewed psychedelic science for clinicians and lay readers. Highly comparable to PsyTech's Research category, with a stronger clinical/scientific tilt.

TypeDirect peer
Description

Podcast- and content-led psychedelic education platform serving curious consumers and clinicians. Comparable to PsyTech in audience and editorial mission, with a stronger audio/community focus.

TypeBroad incumbent
Description

Long-established nonprofit advancing psychedelic research, education, and policy. Comparable to PsyTech in the education/news mission, but with significantly more resources, clinical trial activity, and institutional standing.

TypeEmerging player
Description

Psychedelic education and cultural-advocacy organization publishing articles, hosting convenings, and convening scholars. Comparable to PsyTech in content-led education, with greater emphasis on traditional/indigenous knowledge and conferences.

TypeBroad incumbent
Description

UK-based psychedelic research and policy reform organization producing reports and commentary. Adjacent to PsyTech in covering research and policy, but operates as an established thought leader rather than a daily content publisher.

TypeDirect peer
Description

Long-running online psychedelic culture and education publication. Direct peer in vertical-specialist media, with a more culture/spirituality focus and lower publication cadence than PsyTech.

TypeDirect peer
Description

Psychedelic news and harm-reduction publication serving consumers, patients, and advocates. Comparable to PsyTech in editorial mission and audience, with an explicit harm-reduction editorial stance.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat3 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile4 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Core technology
Revenue estimate
Valuation estimate
Number of profiles
No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

PsyTech

Online Psychedelic News and Education Mediapsytechglobal.com

PsyTech (Psytech Global) is a small online media platform that publishes news, research, education, and business coverage of psychedelics for the general public, mental health patients, and researchers, and offers guided psilocybin truffle experiences in the Netherlands.

What PsyTech does

PsyTech, operating legally as Psytech Global, is a privately held online media and information platform focused on psychedelic science, therapy, and industry. The company publishes articles covering psychedelic news, clinical research summaries, educational content, people profiles, and business developments across eight substance verticals (Ayahuasca, DMT, Ketamine, Kratom, MDMA, Mescaline, Peyote, and Psilocybin), and maintains a free daily email newsletter for subscriber engagement. Content is produced by a small team described as journalists, business education professionals, and medical doctors, with articles referencing peer-reviewed research from institutions including Harvard, Johns Hopkins, NYU, and UCLA.

The underlying product is a WordPress-based content website (psytechglobal.com) with no mobile app, no API, no proprietary software, and no documented AI or ML components; the technology stack is standard web publishing rather than a custom platform. Beyond editorial, PsyTech operates a narrow consumer-services arm providing sitter services and guided ceremony/retreat facilitation for psilocybin truffle experiences in the Netherlands, where such services are legal, and references the ICEERS facilitator-selection framework as a credibility reference.

Commercially, the business appears to rely on advertising and informal affiliate or referral relationships with smartshops and retreat providers; no pricing is disclosed and no enterprise or subscription products are offered. Customer segments are horizontal — the general public interested in psychedelics, mental health patients and advocates, and researchers/healthcare professionals — with no anchor accounts. Headcount is 1–10 employees, no funding rounds are disclosed, and the company is independently owned with no parent or known investor.

PsyTech firmographics

Firmographics
Name
PsyTech
Legal name
Psytech Global
Website
https://psytechglobal.com/
Company type
Private
Founded year
2019
Operating status
Operating
Headcount range
1–10 employees
Short description
PsyTech (Psytech Global) is a small online media platform that publishes news, research, education, and business coverage of psychedelics for the general public, mental health patients, and researchers, and offers guided psilocybin truffle experiences in the Netherlands.
Ownership category
akta.pro rank

Where PsyTech is headquartered

Location

Headquarters

HQ city
Toronto
HQ country
Canada
HQ region
North America

Offices1 record

Markets served

PsyTech business model

Business model
GTM type
B2C
Offering type
Digital Commerce or Content
Cost components
Personnel, Operations, Marketing or Sales, Technology or R&D

Revenue model

  1. Content Publishing & Advertising: The company operates as an online media publication generating content about psychedelics including news, research summaries, educational articles, and people profiles. Revenue appears to be generated through advertising, sponsored content, and affiliate relationships with related services such as smartshops and retreat providers mentioned in their guided psychedelic experience article.

Go-to-market motion1 record

Distribution channels2 records

Marketing channels3 records

PsyTech product offering

Product offering

Core offering

PsyTech (Psytech Global) operates a digital media publication at psytechglobal.com that publishes news, research summaries, educational articles, people profiles, and business coverage focused on psychedelics including psilocybin, LSD, MDMA, ketamine, ayahuasca, DMT, mescaline, peyote, and kratom. Content is produced by journalists, business education professionals, and medical doctors and distributed free of charge through the website and a daily email newsletter. In addition, PsyTech offers sitter and guided ceremony integration services in the Netherlands where psilocybin truffles are legally available through smartshops.

Product overview

PsyTech Global is a content and education platform that publishes psychedelic-related news, research articles, and informational content. The platform covers various psychedelic substances including psilocybin, LSD, MDMA, ketamine, ayahuasca, DMT, mescaline, and peyote through educational articles, research summaries, and people profiles. It does not appear to offer a software product or application with technical integrations.

Differentiator

Problem solved

Functional benefit

Products and services

  • PsyTech Global Content Platform A free online publication providing news, research summaries, educational articles, people profiles, and business coverage focused on psychedelics. It is targeted at general consumers, mental health patients and advocates, researchers, and healthcare professionals, and covers substance-specific categories (Ayahuasca, DMT, Ketamine, Kratom, MDMA, Mescaline, Peyote, Psilocybin).
  • PsyTech Daily Email Newsletter A free daily email newsletter subscription delivering brief updates on psychedelic industry news, research, and developments to subscribed readers, supporting recurring audience engagement.
  • PsyTech Integration and Guided Ceremony Services (Netherlands) In-person sitter and guided ceremony services for individuals seeking supported psilocybin truffle experiences in the Netherlands. Offered to consumers in jurisdictions where such services are legal and uses ICEERS-aligned criteria for selecting safe facilitators.

Quantifiable outcome

  • Articles regularly cited and linked to peer-reviewed research from institutions including Harvard, Johns Hopkins, NYU, UCLA, and major pharmaceutical organizations

Companies that use PsyTech

Customer profile

Segments3 records

Ideal customer profiles4 records

PsyTech technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

PsyTech partnerships and signals

Strategic signal

Partnerships

One partnership is on record.

Scale indicators1 record

Recent moves5 records

Expansion highlights4 records

PsyTech competitors and assessment

Company assessment

Direct peers

  • Lucid News: Psychedelic journalism outlet covering policy, research, and business. Direct peer in the psychedelic-media category with similar news/research/business verticals to PsyTech.
  • Double Blind Magazine: Editorial-led psychedelic media outlet covering news, culture, and policy. Closest direct competitor to PsyTech's content-publishing model and target audience of curious consumers, patients, and professionals.
  • Third Wave: Psychedelic education and media platform offering articles, courses, and a coaching directory. Comparable to PsyTech in vertical specialization and content-led GTM, with an additional layer of paid training services.
  • Psychedelic Science Review: Research-focused publication summarizing peer-reviewed psychedelic science for clinicians and lay readers. Highly comparable to PsyTech's Research category, with a stronger clinical/scientific tilt.
  • Psychedelics Today: Podcast- and content-led psychedelic education platform serving curious consumers and clinicians. Comparable to PsyTech in audience and editorial mission, with a stronger audio/community focus.
  • Reality Sandwich: Long-running online psychedelic culture and education publication. Direct peer in vertical-specialist media, with a more culture/spirituality focus and lower publication cadence than PsyTech.
  • Reset.me: Psychedelic news and harm-reduction publication serving consumers, patients, and advocates. Comparable to PsyTech in editorial mission and audience, with an explicit harm-reduction editorial stance.

Broad incumbents

  • MAPS (Multidisciplinary Association for Psychedelic Studies): Long-established nonprofit advancing psychedelic research, education, and policy. Comparable to PsyTech in the education/news mission, but with significantly more resources, clinical trial activity, and institutional standing.
  • Beckley Foundation: UK-based psychedelic research and policy reform organization producing reports and commentary. Adjacent to PsyTech in covering research and policy, but operates as an established thought leader rather than a daily content publisher.

Emerging players

  • Chacruna Institute: Psychedelic education and cultural-advocacy organization publishing articles, hosting convenings, and convening scholars. Comparable to PsyTech in content-led education, with greater emphasis on traditional/indigenous knowledge and conferences.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat3 records

Key risks6 records

Key highlights6 records

Customer concentration

PsyTech social profiles

Digital presence

PsyTech financial estimates

Financial estimate

Revenue estimate

Valuation estimate

PsyTech leadership team

Management profile

Number of profiles

PsyTech funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

PsyTech M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about PsyTech

What does PsyTech do?

PsyTech (Psytech Global) operates a digital media publication at psytechglobal.com that publishes news, research summaries, educational articles, people profiles, and business coverage focused on psychedelics including psilocybin, LSD, MDMA, ketamine, ayahuasca, DMT, mescaline, peyote, and kratom. Content is produced by journalists, business education professionals, and medical doctors and distributed free of charge through the website and a daily email newsletter. In addition, PsyTech offers sitter and guided ceremony integration services in the Netherlands where psilocybin truffles are legally available through smartshops.

Is PsyTech a public or private company?

PsyTech is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was PsyTech founded?

PsyTech was founded in 2019. It employs 1 to 10 people.

Where is PsyTech based?

PsyTech is headquartered in Toronto, Canada, in the North America region.

How does PsyTech make money?

One revenue line is on record: content Publishing & Advertising.

Who are PsyTech's main competitors?

Direct peers on record are Lucid News, Double Blind Magazine, Third Wave, Psychedelic Science Review, Psychedelics Today, Reality Sandwich and Reset.me. Broad incumbents are MAPS (Multidisciplinary Association for Psychedelic Studies) and Beckley Foundation. Chacruna Institute is listed as an emerging player.

Does PsyTech have an API?

No public API is recorded for PsyTech.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
GlobeNewswireMycotopia Therapies PsyTech Inc. Announces Third Annual Psytech Summit on July 19th and 20th, 2021Mycotopia Therapies announced its third annual Psytech Summit will be held virtually on July 19-20, 2021, with free general admission and $97 premium access. The company holds a 10% interest in PsyTech, and Ehave, Inc. controls about 75.77% of Mycotopia's shares.GlobeNewswire20/20 Global, Inc. PsyTech the World’s Most Recognized Psychedelic Conference to Host Live Webinar on New Approaches to Ketamine-Assisted Treatment Wednesday, January 27th 2021 at 12:00 EST20/20 Global, Inc. announced a complimentary PsyTech webinar on ketamine-assisted treatment, open to investors and the psychedelic community, on January 27th at 12:00 PM ET. The webinar features psychiatrists, anesthesiologists, and psychotherapists, with no login or attendance fees. The company plans to file with FINRA to change its name to Mycotopia Therapy.GlobeNewswirePsyTech Hosts Live Investor Conference & Webinar September 8, 2020: Ethical Business Practice in the Psychedelic SpaceEhave, Inc. announced a virtual investor conference and webinar on ethical business practice in the psychedelic space, open to investors and analysts. The event, moderated by Guy Lieberman, features speakers including Liana Gillooly, David Nikzad, and Stacey Wallin, and is free to attend.GlobeNewswireEhave, Inc. PsyTech The World’s MOST RECOGNIZED PSYCHEDELIC CONFERENCE to Host Live Webinar Featuring World Renowned Williams Richard Lead Clinical Doctor at John Hopkins Wednesday, July 29th 2020 atEhave, Inc. and its subsidiary PsyTech announced a complimentary investor webinar on July 29, 2020, on psychedelic medicine. The event features William A. Richards from Johns Hopkins and is open to investors and the psychedelic community. No fees are charged to attend.GlobeNewswireEhave, Inc. PsyTech Welcomes Todd Shapiro of Red Light Holland as Moderator in the June 17th Webinar The Future of Psychedelics: A TECHNOLOGY PERSPECTIVEEhave, Inc. and PsyTech announced a complimentary virtual investor webinar on June 17, moderated by Todd Shapiro of Red Light Holland. The event, open to investors and the psychedelic community, has over 1,400 registered attendees from 25 countries and five paid sponsors.PR NewswireThe PsyTech Summit Announces Rick Doblin, Founder and Executive Director of MAPS as Keynote Speaker at First-Ever Psychedelic Science, Innovation & Investment Conference in IsraelThe PsyTech Summit announced that Rick Doblin, Founder and Executive Director of the Multidisciplinary Association for Psychedelic Studies (MAPS), will serve as keynote speaker at its inaugural psychedelic science, innovation, and investment conference in Israel on March 29-30, 2020. PsyTech, a division of iCAN: Israel-Cannabis, is organizing the first-ever summit of this kind in Israel focused on the therapeutic potential of psychedelics for mental health conditions including depression, anxiety, and PTSD. The announcement highlights the emergence of for-profit entities in the psychedelic field following decades of non-profit research, set against a global mental health medications market valued at $88.3 billion in 2015.